Redmile Group logo

Redmile Group

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Equity

Clear Labs logo
Clear Labs

Next-generation sequencing

Wing Venture Capital logo
T. Rowe Price Associates logo
Redmile Group logo
Nimble Ventures logo
Menlo Ventures logo
Khosla Ventures logo
HBM Genomics logo
GV logo

Clear Labs develops next-generation sequencing platforms that integrate DNA sequencing, robotics, and cloud-based bioinformatics for diagnostics.

Series D
$30M
01/13/2025
Article
Saluda Medical logo
Saluda Medical

Medical device

Wellington Management logo
TPG Life Sciences Innovation logo
T. Rowe Price Associates logo
Redmile Group logo
Piper Heartland Healthcare Capital logo
Fidelity Management & Research Company logo
Action Potential Venture Capital logo

Saluda Medical develops and commercializes the Evoke® System, a closed-loop spinal cord stimulation device for managing chronic pain.

Equity
$100M
01/10/2025
Article
Candid Therapeutics logo
Candid Therapeutics

Biotechnology

Venrock Healthcare Capital Partners logo
Vida Ventures logo
TCGX logo
Third Rock Ventures logo
Soleus Capital logo
Samsara BioCapital logo
Redmile Group logo
Polaris Innovation Fund logo

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Equity
$370M
09/09/2024
Article
Star Therapeutics logo
Star Therapeutics

Biotechnology

Sofinnova Investments logo
Westlake Village BioPartners logo
OrbiMed logo
Redmile Group logo
RA Capital Management logo
Qatar Investment Authority logo
New Leaf Venture Partners logo
NYBC Ventures logo

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

Series C
$90M
09/05/2023
Article